A global biopharmaceutical leader sought to optimize its pharma marketing mix strategy across four brands in rare diseases, oncology, and neurosciences, aiming for enhanced channel engagement, portfolio-level decisions, and efficient budget allocation to become truly omnichannel—reaching the right HCPs at the right time through optimal channels. Indegene's scalable, data-driven software provided AI-powered analytics, physician affinity models, and predictive insights that unified multi-channel campaigns, personalized HCP interactions, and maximized ROI, transforming fragmented efforts into measurable commercial impact with streamlined budget optimization and precise targeting.

Join for free to read